Growth Metrics

BioLineRx (BLRX) Profit After Tax Growth (1y) (2014 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 65.80%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -290.15%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 59.59%
7 Evaxion A 64.16 Bn 64.14 Bn - -129.68%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1,228.66%
10 BioLineRx 9.32 Bn 9.30 Bn 154,000.00 29.84%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 29.84%
Sep 30, 2025 83.22%
Jun 30, 2025 714.05%
Mar 31, 2025 836.64%
Dec 31, 2024 77.05%
Sep 30, 2024 63.66%
Jun 30, 2024 -97.39%
Mar 31, 2024 94.28%
Dec 31, 2023 -142.26%
Sep 30, 2023 -134.01%
Jun 30, 2023 149.16%
Mar 31, 2023 -146.69%
Dec 31, 2022 -33.16%
Sep 30, 2022 -19.79%
Jun 30, 2022 8.78%
Mar 31, 2022 51.63%
Dec 31, 2021 64.10%
Sep 30, 2021 -23.78%
Jun 30, 2021 1.06%
Mar 31, 2021 -53.38%
Dec 31, 2020 -21.48%
Sep 30, 2020 -17.27%
Jun 30, 2020 23.43%
Mar 31, 2020 -7.96%
Dec 31, 2019 -74.59%
Sep 30, 2019 37.73%
Jun 30, 2019 14.56%
Mar 31, 2019 0.69%
Dec 31, 2018 23.18%
Sep 30, 2018 12.69%
Jun 30, 2018 -2.23%
Mar 31, 2018 -27.66%
Dec 31, 2017 -71.69%
Sep 30, 2017 -67.12%
Jun 30, 2017 231.11%
Mar 31, 2017 -39.15%
Dec 31, 2016 -17.33%
Sep 30, 2016 -166.54%
Jun 30, 2016 22.35%
Mar 31, 2016 19.07%
Dec 31, 2015 12.90%
Sep 30, 2015 -132.29%
Jun 30, 2015 -18.27%
Mar 31, 2015 -103.83%
Dec 31, 2014 -111.55%
Sep 30, 2014 72.87%
Jun 30, 2014 -7.22%
Mar 31, 2014 39.90%